SERELAXIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 20:46:52 GMT 2025` Edited by `admin` on `Tue Apr 01 20:46:52 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	W0122B976Y
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

serelaxin [INN]

Preferred Name

English

SERELAXIN

Official Name

English

RLX-030

Code

English

RECOMBINANT HUMAN RELAXIN

Common Name

English

HUMAN RELAXIN RECOMBINANT

Common Name

English

SERELAXIN [JAN]

Common Name

English

SERELAXIN [USAN]

Common Name

English

RLX030

Code

English

HUMAN RELAXIN 2 (RELAXIN H2)

Common Name

English

Serelaxin [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-ATC

C01DX21

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

FDA ORPHAN DRUG

92995

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

NCI_THESAURUS

C29707

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

WHO-VATC

QC01DX21

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

EMA ASSESSMENT REPORTS

REASANZ (REFUSED: HEART FAILURE)

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

Code System Code Type Description

NCI_THESAURUS

C152342

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

PUBCHEM

71300755

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

EPA CompTox

DTXSID40244082

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

DRUG BANK

DB05794

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

WIKIPEDIA

Serelaxin

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

ChEMBL

CHEMBL2108358

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

FDA UNII

W0122B976Y

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

CAS

99489-94-8

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

INN

9488

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

EVMPD

SUB119779

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

USAN

ZZ-76

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

SMS_ID

100000143254

Created by admin on Tue Apr 01 20:46:52 GMT 2025 , Edited by admin on Tue Apr 01 20:46:52 GMT 2025

PRIMARY

From	To
1_11	2_11
1_23	2_24
2_10	2_15

Related Record Type Details


					W0122B976Y

SERELAXIN

ACTIVE MOIETY

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[2_1]		E		PIDOLIC ACID	SZB83O1W42

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL